articleProceedings of the National Academy of SciencesMar 26, 2012BRONZE OA

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

California Institute for Regenerative Medicine · Institute for Stem Cell Biology and Regenerative Medicine · +7 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

CD47, a "don't eat me" signal for phagocytic cells, is expressed on the surface of all human solid tumor cells. Analysis of patient tumor and matched adjacent normal (nontumor) tissue revealed that CD47 is overexpressed on cancer cells. CD47 mRNA expression levels correlated with a decreased probability of survival for multiple types of cancer. CD47 is a ligand for SIRPα, a protein expressed on macrophages and dendritic cells. In vitro, blockade of CD47 signaling using targeted monoclonal antibodies enabled macrophage phagocytosis of tumor cells that were otherwise protected. Administration of anti-CD47 antibodies inhibited tumor growth in orthotopic immunodeficient mouse xenotransplantation models established…

No related works found for this paper.

Funding